Methyl 5-bromo-2-(methylamino)benzoate, 95.0%, 250mg

(3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxylic acid, 97.0%, 250mg

2-MORPHOLINOCYCLOPENTANAMINE, 95.0%, 1g

(S)-2-Aminoheptan-3-one hydrochloride, 95.0%, 250mg

3-Methyl-1H-indene-2-carboxylic acid, 97.0%, 250mg

Ethyl 3-fluoro-4-methylbenzoate, 95.0%, 100g

AzBTS [=2,2'-Azinobis(3-ethylbenzothiazoline-6-sulfonic Acid Ammonium Salt)] [for Biochemical Research]>98.0%(T)1g

(S)-METHYL 2-(N-((2'-(1H-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL)METHYL)PENTANAMIDO)-3-METHYLBUTANOATE, 95%, 25g

Methyl 3-cyclobutyl-3-oxopropanoate, 95.0%, 1g

Bromoacetyl Chloride>85.0%(GC)500g

3-BROMO-5-CHLORO-4-HYDROXYBENZOIC ACID, 95%, 250mg

(3S)-3-(Difluoromethoxy)piperidine hydrochloride, 98%, 500mg

N-(2,4-Dinitrophenyl)-6-aminohexanoic Acid>95.0%(HPLC)(T)100mg